Emergent Biosolutions (EBS) Stock Price, Quote & News

Company Profile

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botul...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 240-631-3200

Fax: 240-631-3203

Website: www.emergentbiosolutions.com

Address:

300 Professional Drive, Suite 400, Gaithersburg, United States

alwayzwong Mar. 21 at 7:54 PM

$EBS

0 · Reply

ComradeKomisar Mar. 21 at 7:51 PM

$EBS Morgan Stanley: 50% of Russell 3000 stocks are already down 20%+. That happens to be our index. Half the market is in a bear market right now.

1 · Reply

billywilliamz Mar. 21 at 3:41 PM

$EBS who the fug is that guy

0 · Reply

ComradeKomisar Mar. 21 at 2:12 PM

$EBS Does Shlomo know this?

0 · Reply

billywilliamz Mar. 21 at 1:58 PM

$EBS he may be papa but I’m daddy

1 · Reply

WinstonSmith33 Mar. 21 at 10:15 AM

$EBS Do you want to say that Billiam has bought more shares than Papa in the real world?

1 · Reply

ComradeKomisar Mar. 21 at 4:24 AM

$EBS Not really. If there was a sale there would have been a Form 4. You can't compare the share accounting in Form 4 with that of a Proxy filing. The meaning of 'beneficially owned' in Form 4 has a 'pecuniary/economic interest' test, which is a broader definition, and therefore Form 4 shows a higher balance. The proxy document has a 'voting or investment power' test, and most likely excludes shares in company escrow pending a performance condition where Papa has economic interest the but company still retains control. Those shares you're looking for are probably in the other 'buckets'. I checked Rich's share balance. The same (non) problem there.

0 · Reply

tjk21 Mar. 20 at 9:40 PM

$EBS

0 · Reply

billywilliamz Mar. 20 at 9:26 PM

$EBS only 2 transactions listed. Probably because certain shares were awarded RSU?

1 · Reply

billywilliamz Mar. 20 at 9:20 PM

$EBS

1 · Reply

Mpox Is on the Rise. 3 Vaccine Stocks Worth a Second Look.

SIGA

Mar 3, 2026, 8:00 AM EST - 18 days ago

Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

Feb 28, 2026, 9:47 AM EST - 21 days ago

Emergent BioSolutions Earnings: Revenue, Margins, And GAAP Losses Paint A Mixed Picture

Feb 26, 2026, 11:58 PM EST - 22 days ago

Emergent BioSolutions Inc. (EBS) Q4 2025 Earnings Call Prepared Remarks Transcript

Feb 26, 2026, 4:05 PM EST - 23 days ago

Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

Feb 26, 2026, 4:01 PM EST - 23 days ago

Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada's Leadership in Health Preparedness

Feb 26, 2026, 4:01 PM EST - 23 days ago

Emergent BioSolutions Announces New $50 Million Stock Repurchase Program

Feb 12, 2026, 6:00 PM EST - 5 weeks ago

Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks

Feb 12, 2026, 9:02 AM EST - 5 weeks ago

Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Jan 15, 2026, 1:08 PM EST - 2 months ago

NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading

Jan 14, 2026, 11:55 PM EST - 2 months ago

Emergent BioSolutions Inc. (EBS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 7:30 AM EST - 2 months ago

Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation

Jan 8, 2026, 4:30 PM EST - 2 months ago

Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026

Jan 8, 2026, 8:00 AM EST - 2 months ago

Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa

Jan 7, 2026, 7:59 AM EST - 2 months ago

Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 12, 2025, 8:30 AM EST - 3 months ago

Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site

Nov 18, 2025, 8:00 AM EST - 4 months ago

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access

Nov 12, 2025, 4:01 PM EST - 4 months ago

Emergent BioSolutions Announces Retirement of Dr. Louis W. Sullivan from Board of Directors

Nov 6, 2025, 11:00 PM EST - 4 months ago

Emergent BioSolutions: Solid Q3, Expecting Better Days To Come

Oct 29, 2025, 8:56 PM EDT - 5 months ago

Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript

Oct 29, 2025, 4:15 PM EDT - 5 months ago

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

Oct 28, 2025, 8:00 AM EDT - 5 months ago

Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness

Oct 8, 2025, 7:45 AM EDT - 5 months ago

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

Sep 24, 2025, 4:05 PM EDT - 6 months ago

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

Sep 19, 2025, 8:34 AM EDT - 6 months ago

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

Sep 15, 2025, 8:35 AM EDT - 6 months ago

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

Sep 9, 2025, 7:30 AM EDT - 6 months ago

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

Sep 2, 2025, 7:40 AM EDT - 7 months ago

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

Aug 29, 2025, 8:05 AM EDT - 7 months ago

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

Aug 27, 2025, 8:01 AM EDT - 7 months ago

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Aug 21, 2025, 8:45 AM EDT - 7 months ago

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

Aug 12, 2025, 12:46 PM EDT - 7 months ago

Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally

Aug 7, 2025, 7:31 PM EDT - 8 months ago

Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:15 PM EDT - 8 months ago

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

Jul 28, 2025, 8:50 AM EDT - 8 months ago

Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives

Jul 28, 2025, 8:50 AM EDT - 8 months ago

New Publication in Expert Review of Anti-infective Therapy Evaluates Brincidofovir as Potential Antiviral Treatment for Mpox

Jul 15, 2025, 7:30 AM EDT - 8 months ago

Emergent BioSolutions to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 8, 2025, 4:45 PM EDT - 9 months ago

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

Jul 2, 2025, 4:05 PM EDT - 9 months ago

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

Jun 23, 2025, 8:05 AM EDT - 9 months ago

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

Jun 20, 2025, 2:25 PM EDT - 9 months ago

Emergent BioSolutions: Strategic Turnaround Proving Tricky, But I'm Still Hopeful

Jun 20, 2025, 8:13 AM EDT - 9 months ago

Emergent BioSolutions Announces Addition to Russell 3000® Index

Jun 5, 2025, 7:00 AM EDT - 10 months ago

Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

May 7, 2025, 10:01 PM EDT - 11 months ago

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 11 months ago

Emergent BioSolutions Reports First Quarter 2025 Financial Results

May 1, 2025, 5:07 PM EDT - 11 months ago

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

Apr 22, 2025, 8:00 AM EDT - 11 months ago

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Emergent BioSolutions Announces Stock Repurchase Program

Mar 20, 2025, 4:30 PM EDT - 1 year ago

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

Mar 20, 2025, 8:06 AM EDT - 1 year ago

Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

alwayzwong Mar. 21 at 7:54 PM

$EBS

0 · Reply

ComradeKomisar Mar. 21 at 7:51 PM

$EBS Morgan Stanley: 50% of Russell 3000 stocks are already down 20%+. That happens to be our index. Half the market is in a bear market right now.

1 · Reply

billywilliamz Mar. 21 at 3:41 PM

$EBS who the fug is that guy

0 · Reply

ComradeKomisar Mar. 21 at 2:12 PM

$EBS Does Shlomo know this?

0 · Reply

billywilliamz Mar. 21 at 1:58 PM

$EBS he may be papa but I’m daddy

1 · Reply

WinstonSmith33 Mar. 21 at 10:15 AM

$EBS Do you want to say that Billiam has bought more shares than Papa in the real world?

1 · Reply

ComradeKomisar Mar. 21 at 4:24 AM

0 · Reply

tjk21 Mar. 20 at 9:40 PM

$EBS

0 · Reply

billywilliamz Mar. 20 at 9:26 PM

$EBS only 2 transactions listed. Probably because certain shares were awarded RSU?

1 · Reply

billywilliamz Mar. 20 at 9:20 PM

$EBS

1 · Reply

WinstonSmith33 Mar. 20 at 9:15 PM

$EBS LOL, no idea when, but our Papa sold over 200k shares. Another "brain" besides my favorite Poor Rich. These guys don't believe in their own company and just swings! Once again, the worst part of this company - risk management. "On May 13, 2025, Joseph Papa, President and Chief Executive Officer of Emergent BioSolutions Inc EBS purchased 60,000 shares of the company, as reported in the SEC Filing. Following this transaction, the insider now owns a total of 342,500 shares of the company."

0 · Reply

Ithaca2018 Mar. 20 at 9:06 PM

$EBS Nice green candle before the close, that's what I meant! Have a nice weekend;-)

1 · Reply

WinstonSmith33 Mar. 20 at 9:05 PM

$EBS Annual report and proxy statements are online FYI. Interesting that Papa has now only 117.112 shares. As I remember he had at least 350.000 shares at some point. Anyone? https://investors.emergentbiosolutions.com/sec-filings

2 · Reply

billywilliamz Mar. 20 at 8:45 PM

$EBS quadwitchjng hence the big AH volume…. Shoukd be interesting to see how it plays Monday but going green in end of day is promising while everything else sold off hard.

0 · Reply